FINANCIAL STATEMENT & OTHER INFORMATION 158 Al-`Aqar Healthcare REIT | Annual Report 2024 The Group The Fund 2024 RM 2023 RM 2024 RM 2023 RM Cash flows from financing activities Finance costs paid on Islamic financing (34,227,437) (36,525,112) (34,227,437) (36,525,112) Transaction costs paid (259,999) (180,000) (259,999) (180,000) Decrease in amount due to a subsidiary - - (28,536,541) (84,774) Income distributions (66,076,382) (78,266,014) (64,773,002) (78,266,014) Repayment of Islamic financing - (100,000,000) - (100,000,000) Net proceeds from issuance of units - 98,349,283 - 98,349,283 Net proceeds from Islamic financing - - - - Net cash used in financing activities (100,563,818) (116,621,843) (127,796,979) (116,706,617) Net increase/(decrease) in cash and cash equivalents 8,179,901 (13,870,162) 7,666,604 (9,983,750) Effects of changes in exchange rates (5,061,402) 2,009,198 - - Effects of foreign currency translation on cash and cash equivalents (132,601) 55,712 (132,601) 55,712 Cash and cash equivalents at beginning of year 84,286,760 96,092,012 68,368,420 78,296,458 Cash and cash equivalents at end of year (Note 14) 87,272,658 84,286,760 75,902,423 68,368,420 The accompanying accounting policies and explanatory notes form an integral part of the financial statements. STATEMENTS OF CASH FLOWS For the year ended 31 December 2024 (cont’d)
RkJQdWJsaXNoZXIy NDgzMzc=